Cas9‐Cleavage Sequences in Size‐Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T Cells
Authors:
- 19 May 2021
- journal article
- research article
- Published by Wiley in Small Methods
- Vol. 5 (7) , 2100071
Abstract
T cell genome editing holds great promise to advance a range of immunotherapies but is encumbered by the dependence on difficult‐to‐produce and expensive viral vectors. Here, small double‐stranded plasmid DNA modified to mediate high‐efficiency homologous recombination is designed. The resulting chimeric antigen receptor (CAR)‐T cells display a similar phenotype, transcriptional profile, and in vivo potency to CAR‐T cells generated using adeno‐associated viral vector. This method should simplify and accelerate the use of precision engineering to produce edited T cells for research and clinical purposes.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (31971324, 31971125)
- Natural Science Foundation of Zhejiang Province (LR20H160003)
This publication has 27 references indexed in Scilit:
- An efficient gene knock-in strategy using 5′-modified double-stranded DNA donors with short homology armsNature Chemical Biology, 2019
- Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiencyNature Biotechnology, 2019
- HIV-specific humoral immune responses by CRISPR/Cas9-edited B cellsJournal of Experimental Medicine, 2019
- An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cellsGene, 2019
- Reprogramming human T cell function and specificity with non-viral genome targetingNature, 2018
- Chimeric Antigen Receptor TherapyNew England Journal of Medicine, 2018
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejectionNature, 2017
- Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transferEMBO Molecular Medicine, 2016
- Generation of knock-in primary human T cells using Cas9 ribonucleoproteinsProceedings of the National Academy of Sciences, 2015
- Development and Applications of CRISPR-Cas9 for Genome EngineeringCell, 2014